Proposed Bill Could Fuel the Opioid Epidemic

George M. Karavetsos’ editorial was published in The Hill on October 30, 2017. George M. Karavetsos is a partner with the global law firm DLA Piper. He formerly served as the director of the U.S. Food and Drug Administration’s Office of Criminal Investigations and chief of the Narcotics Section and the executive assistant U.S. attorney in the Southern District of Florida…

[...]

Former FBI Director Discusses the Dangers of Allowing Drug Importation in Radio Interview

Freeh warned that allowing drug importation from Canada was akin to allowing drugs to be imported from anywhere. Quality would be at risk, and the opioid crisis, an epidemic that killed over 33,000 Americans in 2015, would only get worse. He said that allowing drug importation, “…will not only fuel that, but it will also, in my opinion, encourage a lot of criminal groups and organizations that heretofore have not been involved in this trade, but will see huge opportunities to enter the market.”

[...]

Op-Ed: Why Drug Importation Is Flawed Policy

Mike Leavitt | March 20, 2017 With the issue of prescription drug importation being debated on Capitol Hill again, mark me in the skeptical camp. As a matter of safety and practical policymaking, drug importation simply doesn’t work. It is not by happenstance that our country has the world’s safest drug supply. Counterfeit medicines are proliferating…

[...]